Online ISSN: 2515-8260

Keywords : Hydroxychloroquine


Dhayanithi. J; Smiline Girija A. S; Brundha M. P

European Journal of Molecular & Clinical Medicine, 2020, Volume 7, Issue 1, Pages 412-420

With the raising concerns on the mortality rate in the recent covid pandemic, the lacunae of proper treatment strategy plays a vital factor. Since there is no approved medication for COVID-19, medications involving hydroxychloroquine sulfate and chloroquine phosphate were recently recommended. The National Medical Products Administration of China has approved Favilavir, an antiviral medication, with minimal side effects and a moderate control on viral replication. Remdesvir, another antiviral, has drawn the attention of several researchers to treat the novel COVID-19 virus as COVID-19 is identical to SARS and MERS viruses. Remdesvir, was successful in the previous outbreaks of SARS and MERS. Some researchers also suggest high doses of vitamin C supplementation may improve the patient's condition. This review thus provides a basic overview on the recommended medication and urges the need to develop novel anti-covid drugs and vaccines


A.Sankari Niveditha; Lakshminarayanan Arivarasu

European Journal of Molecular & Clinical Medicine, 2020, Volume 7, Issue 1, Pages 476-485

The aim of the study is to create awareness and knowledge of Hydroxychloroquine among the general public. Hydroxychloroquine (CHQ) was first recognized as a potent antimalarial agent. It was used for the prevention and treatment of acute attacks of malaria. Hydroxychloroquine is FDA-approved to prevent and treat malaria and also to treat the autoimmune disease, rheumatoid arthritis and lupus. Quine advanced forms are chloroquine and hydroxychloroquine used for antimalarial treatment. Hydroxychloroquine has immunomodulatory effects and it may cause retinopathy. A survey was conducted among the general public during the pandemic COVID 19. The study setting was an online setting with a varied population. The sample size included 100 people and predominantly were South Indian population. The sampling method was a simple randomized method. Both the gender were included and the population was above 18 years. From the study, we come to know that 55% of people are aware of the drug hydroxychloroquine. 47% of the people were aware of the side effects of the drug hydroxychloroquine. 92% of people had knowledge about India exploring drugs to foriegn nations. 91% of people agreed that hydroxychloroquine along with common antibiotics can be used for the treatment of COVID 19. 43% of people are aware of the contraindications of the drug. Hydroxychloroquine and chloroquine can cause abnormal heart rhythms such as QT interval prolongation and rapid heart rate called ventricular tachycardia. Patients with other health issues are at higher risk when receiving these medications. Hence from the study we can conclude that the study population has only minimum knowledge and awareness about the drug hydroxychloroquine. This study helps in improving the knowledge and creating awareness among the people.